Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District—United States, December 2020–January 2021 Article Swipe
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1093/cid/ciab332
Background To inform prevention strategies, we assessed the extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and settings in which transmission occurred in a Georgia public school district. Methods During 1 December 2020–22 January 2021, SARS-CoV-2–infected index cases and their close contacts in schools were identified by school and public health officials. For in-school contacts, we assessed symptoms and offered SARS-CoV-2 reverse-transcription polymerase chain reaction (RT-PCR) testing; performed epidemiologic investigations and whole-genome sequencing to identify in-school transmission; and calculated secondary attack rate (SAR) by school setting (eg, sports, elementary school classroom), index case role (ie, staff, student), and index case symptomatic status. Results We identified 86 index cases and 1119 contacts, 688 (61.5%) of whom received testing. Fifty-nine of 679 (8.7%) contacts tested positive; 15 of 86 (17.4%) index cases resulted in ≥2 positive contacts. Among 55 persons testing positive with available symptom data, 31 (56.4%) were asymptomatic. Highest SARs were in indoor, high-contact sports settings (23.8% [95% confidence interval {CI}, 12.7%–33.3%]), staff meetings/lunches (18.2% [95% CI, 4.5%–31.8%]), and elementary school classrooms (9.5% [95% CI, 6.5%–12.5%]). The SAR was higher for staff (13.1% [95% CI, 9.0%–17.2%]) vs student index cases (5.8% [95% CI, 3.6%–8.0%]) and for symptomatic (10.9% [95% CI, 8.1%–13.9%]) vs asymptomatic index cases (3.0% [95% CI, 1.0%–5.5%]). Conclusions Indoor sports may pose a risk to the safe operation of in-person learning. Preventing infection in staff members, through measures that include coronavirus disease 2019 vaccination, is critical to reducing in-school transmission. Because many positive contacts were asymptomatic, contact tracing should be paired with testing, regardless of symptoms.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/cid/ciab332
- https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdf
- OA Status
- hybrid
- Cited By
- 28
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3155347526
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3155347526Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/cid/ciab332Digital Object Identifier
- Title
-
Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District—United States, December 2020–January 2021Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-04-16Full publication date if available
- Authors
-
Jenna R. Gettings, Jeremy A.W. Gold, Anne Kimball, Kaitlin Forsberg, Colleen Scott, Anna Uehara, Suxiang Tong, Marisa Hast, Megan Swanson, Elana Morris, Emeka Oraka, Olivia Almendares, Ebony S. Thomas, Lemlem Mehari, Jazmyn McCloud, Gurleen Roberts, Deanna Crosby, Abirami Balajee, Eleanor Burnett, Rebecca J. Chancey, Peter W. Cook, Morgane Donadel, Catherine Espinosa, Mary E. Evans, Katherine E. Fleming-Dutra, Catalina Forero, Esther A. Kukielka, Yan Li, Paula L. Marcet, Kiren Mitruka, Jasmine Y. Nakayama, Yoshinori Nakazawa, Michelle O’Hegarty, Caroline Pratt, Marion E. Rice, Roxana M. Rodríguez Stewart, Raquel Sabogal, Emanny Sánchez, Andrés Velasco-Villa, Mark K. Weng, Jing Zhang, Grant Rivera, Tonia Parrott, Rachel S. Franklin, Janet Memark, Cherie Drenzek, Aron J. Hall, Hannah L. Kirking, Jacqueline E. Tate, Snigdha VallabhaneniList of authors in order
- Landing page
-
https://doi.org/10.1093/cid/ciab332Publisher landing page
- PDF URL
-
https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdfDirect OA link when available
- Concepts
-
Medicine, Asymptomatic, Index case, Confidence interval, Transmission (telecommunications), Public health, Pediatrics, Attack rate, Internal medicine, Family medicine, Demography, Epidemiology, Disease, Pathology, Engineering, Sociology, Electrical engineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
28Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 5, 2023: 4, 2022: 10, 2021: 7Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3155347526 |
|---|---|
| doi | https://doi.org/10.1093/cid/ciab332 |
| ids.doi | https://doi.org/10.1093/cid/ciab332 |
| ids.mag | 3155347526 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33864375 |
| ids.openalex | https://openalex.org/W3155347526 |
| fwci | 1.90173623 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000086382 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | COVID-19 |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D016358 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Contact Tracing |
| mesh[2].qualifier_ui | Q000453 |
| mesh[2].descriptor_ui | D005845 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | epidemiology |
| mesh[2].descriptor_name | Georgia |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D006801 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Humans |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D000086402 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | SARS-CoV-2 |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D012574 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Schools |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D013334 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Students |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000086382 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | COVID-19 |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D016358 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Contact Tracing |
| mesh[9].qualifier_ui | Q000453 |
| mesh[9].descriptor_ui | D005845 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | epidemiology |
| mesh[9].descriptor_name | Georgia |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000086402 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | SARS-CoV-2 |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D012574 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Schools |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D013334 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Students |
| type | article |
| title | Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District—United States, December 2020–January 2021 |
| biblio.issue | 2 |
| biblio.volume | 74 |
| biblio.last_page | 326 |
| biblio.first_page | 319 |
| grants[0].funder | https://openalex.org/F4320332162 |
| grants[0].award_id | |
| grants[0].funder_display_name | Centers for Disease Control and Prevention |
| topics[0].id | https://openalex.org/T11754 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9988999962806702 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 detection and testing |
| topics[1].id | https://openalex.org/T11243 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.998199999332428 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Respiratory viral infections research |
| topics[2].id | https://openalex.org/T10168 |
| topics[2].field.id | https://openalex.org/fields/32 |
| topics[2].field.display_name | Psychology |
| topics[2].score | 0.9936000108718872 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3203 |
| topics[2].subfield.display_name | Clinical Psychology |
| topics[2].display_name | COVID-19 and Mental Health |
| funders[0].id | https://openalex.org/F4320332162 |
| funders[0].ror | https://ror.org/042twtr12 |
| funders[0].display_name | Centers for Disease Control and Prevention |
| is_xpac | False |
| apc_list.value | 4320 |
| apc_list.currency | USD |
| apc_list.value_usd | 4320 |
| apc_paid.value | 4320 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4320 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8633449673652649 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777910003 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7878574132919312 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1707292 |
| concepts[1].display_name | Asymptomatic |
| concepts[2].id | https://openalex.org/C447327 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7049317359924316 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1639798 |
| concepts[2].display_name | Index case |
| concepts[3].id | https://openalex.org/C44249647 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6423853635787964 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[3].display_name | Confidence interval |
| concepts[4].id | https://openalex.org/C761482 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5348379015922546 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q118093 |
| concepts[4].display_name | Transmission (telecommunications) |
| concepts[5].id | https://openalex.org/C138816342 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5206155776977539 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q189603 |
| concepts[5].display_name | Public health |
| concepts[6].id | https://openalex.org/C187212893 |
| concepts[6].level | 1 |
| concepts[6].score | 0.51790851354599 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[6].display_name | Pediatrics |
| concepts[7].id | https://openalex.org/C37701844 |
| concepts[7].level | 3 |
| concepts[7].score | 0.43908584117889404 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3955915 |
| concepts[7].display_name | Attack rate |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3525781035423279 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C512399662 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3343952000141144 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[9].display_name | Family medicine |
| concepts[10].id | https://openalex.org/C149923435 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3252999186515808 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q37732 |
| concepts[10].display_name | Demography |
| concepts[11].id | https://openalex.org/C107130276 |
| concepts[11].level | 2 |
| concepts[11].score | 0.31429773569107056 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q133805 |
| concepts[11].display_name | Epidemiology |
| concepts[12].id | https://openalex.org/C2779134260 |
| concepts[12].level | 2 |
| concepts[12].score | 0.16593825817108154 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[12].display_name | Disease |
| concepts[13].id | https://openalex.org/C142724271 |
| concepts[13].level | 1 |
| concepts[13].score | 0.09110888838768005 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[13].display_name | Pathology |
| concepts[14].id | https://openalex.org/C127413603 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[14].display_name | Engineering |
| concepts[15].id | https://openalex.org/C144024400 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q21201 |
| concepts[15].display_name | Sociology |
| concepts[16].id | https://openalex.org/C119599485 |
| concepts[16].level | 1 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q43035 |
| concepts[16].display_name | Electrical engineering |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8633449673652649 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/asymptomatic |
| keywords[1].score | 0.7878574132919312 |
| keywords[1].display_name | Asymptomatic |
| keywords[2].id | https://openalex.org/keywords/index-case |
| keywords[2].score | 0.7049317359924316 |
| keywords[2].display_name | Index case |
| keywords[3].id | https://openalex.org/keywords/confidence-interval |
| keywords[3].score | 0.6423853635787964 |
| keywords[3].display_name | Confidence interval |
| keywords[4].id | https://openalex.org/keywords/transmission |
| keywords[4].score | 0.5348379015922546 |
| keywords[4].display_name | Transmission (telecommunications) |
| keywords[5].id | https://openalex.org/keywords/public-health |
| keywords[5].score | 0.5206155776977539 |
| keywords[5].display_name | Public health |
| keywords[6].id | https://openalex.org/keywords/pediatrics |
| keywords[6].score | 0.51790851354599 |
| keywords[6].display_name | Pediatrics |
| keywords[7].id | https://openalex.org/keywords/attack-rate |
| keywords[7].score | 0.43908584117889404 |
| keywords[7].display_name | Attack rate |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.3525781035423279 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/family-medicine |
| keywords[9].score | 0.3343952000141144 |
| keywords[9].display_name | Family medicine |
| keywords[10].id | https://openalex.org/keywords/demography |
| keywords[10].score | 0.3252999186515808 |
| keywords[10].display_name | Demography |
| keywords[11].id | https://openalex.org/keywords/epidemiology |
| keywords[11].score | 0.31429773569107056 |
| keywords[11].display_name | Epidemiology |
| keywords[12].id | https://openalex.org/keywords/disease |
| keywords[12].score | 0.16593825817108154 |
| keywords[12].display_name | Disease |
| keywords[13].id | https://openalex.org/keywords/pathology |
| keywords[13].score | 0.09110888838768005 |
| keywords[13].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1093/cid/ciab332 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S72350973 |
| locations[0].source.issn | 1058-4838, 1537-6591 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1058-4838 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Clinical Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | public-domain |
| locations[0].pdf_url | https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/public-domain |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/cid/ciab332 |
| locations[1].id | pmid:33864375 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33864375 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8083290 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Clin Infect Dis |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8083290 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5068993745 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2540-2172 |
| authorships[0].author.display_name | Jenna R. Gettings |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210130616 |
| authorships[0].affiliations[0].raw_affiliation_string | Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[0].affiliations[1].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I4210140731 |
| authorships[0].affiliations[2].raw_affiliation_string | Georgia Department of Public Health, Atlanta, Georgia, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[0].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[0].institutions[1].id | https://openalex.org/I4210130616 |
| authorships[0].institutions[1].ror | https://ror.org/03v64vs34 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | Epidemic Intelligence Service |
| authorships[0].institutions[2].id | https://openalex.org/I4210140731 |
| authorships[0].institutions[2].ror | https://ror.org/04wcf8366 |
| authorships[0].institutions[2].type | government |
| authorships[0].institutions[2].lineage | https://openalex.org/I4210140731 |
| authorships[0].institutions[2].country_code | US |
| authorships[0].institutions[2].display_name | Georgia Department of Public Health |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jenna R Gettings |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Georgia Department of Public Health, Atlanta, Georgia, USA |
| authorships[1].author.id | https://openalex.org/A5054408037 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5054-7616 |
| authorships[1].author.display_name | Jeremy A.W. Gold |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210130616 |
| authorships[1].affiliations[0].raw_affiliation_string | Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[1].affiliations[1].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[1].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[1].institutions[1].id | https://openalex.org/I4210130616 |
| authorships[1].institutions[1].ror | https://ror.org/03v64vs34 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Epidemic Intelligence Service |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jeremy A W Gold |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[2].author.id | https://openalex.org/A5076026079 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1487-7113 |
| authorships[2].author.display_name | Anne Kimball |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[2].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210130616 |
| authorships[2].affiliations[1].raw_affiliation_string | Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[2].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[2].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[2].institutions[1].id | https://openalex.org/I4210130616 |
| authorships[2].institutions[1].ror | https://ror.org/03v64vs34 |
| authorships[2].institutions[1].type | government |
| authorships[2].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | Epidemic Intelligence Service |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Anne Kimball |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[3].author.id | https://openalex.org/A5036896044 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-5779-2446 |
| authorships[3].author.display_name | Kaitlin Forsberg |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[3].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[3].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[3].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kaitlin Forsberg |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[4].author.id | https://openalex.org/A5008894942 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1553-8239 |
| authorships[4].author.display_name | Colleen Scott |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[4].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[4].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[4].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Colleen Scott |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[5].author.id | https://openalex.org/A5009609962 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-9345-3575 |
| authorships[5].author.display_name | Anna Uehara |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[5].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[5].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[5].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[5].institutions[0].type | government |
| authorships[5].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Anna Uehara |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[6].author.id | https://openalex.org/A5007440156 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8439-8826 |
| authorships[6].author.display_name | Suxiang Tong |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[6].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[6].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[6].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Suxiang Tong |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[7].author.id | https://openalex.org/A5064306958 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2471-6700 |
| authorships[7].author.display_name | Marisa Hast |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[7].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[7].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[7].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Marisa Hast |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[8].author.id | https://openalex.org/A5029094239 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-1122-7975 |
| authorships[8].author.display_name | Megan Swanson |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[8].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[8].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[8].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Megan R Swanson |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[9].author.id | https://openalex.org/A5043510198 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-2105-1336 |
| authorships[9].author.display_name | Elana Morris |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[9].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[9].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[9].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Elana Morris |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[10].author.id | https://openalex.org/A5102869182 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0927-5575 |
| authorships[10].author.display_name | Emeka Oraka |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1343953105 |
| authorships[10].affiliations[0].raw_affiliation_string | General Dynamics Information Technology, Falls Church, Virginia, USA |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[10].affiliations[1].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[10].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[10].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[10].institutions[1].id | https://openalex.org/I1343953105 |
| authorships[10].institutions[1].ror | https://ror.org/05pyq8e17 |
| authorships[10].institutions[1].type | company |
| authorships[10].institutions[1].lineage | https://openalex.org/I1343953105 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | General Dynamics (United States) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Emeka Oraka |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, General Dynamics Information Technology, Falls Church, Virginia, USA |
| authorships[11].author.id | https://openalex.org/A5071457160 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-2524-8937 |
| authorships[11].author.display_name | Olivia Almendares |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[11].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[11].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[11].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Olivia Almendares |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[12].author.id | https://openalex.org/A5019320007 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-7966-1316 |
| authorships[12].author.display_name | Ebony S. Thomas |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210140731 |
| authorships[12].affiliations[0].raw_affiliation_string | Georgia Department of Public Health, Atlanta, Georgia, USA |
| authorships[12].institutions[0].id | https://openalex.org/I4210140731 |
| authorships[12].institutions[0].ror | https://ror.org/04wcf8366 |
| authorships[12].institutions[0].type | government |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210140731 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Georgia Department of Public Health |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Ebony S Thomas |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Georgia Department of Public Health, Atlanta, Georgia, USA |
| authorships[13].author.id | https://openalex.org/A5009452578 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Lemlem Mehari |
| authorships[13].affiliations[0].raw_affiliation_string | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Lemlem Mehari |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[14].author.id | https://openalex.org/A5011176565 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Jazmyn McCloud |
| authorships[14].affiliations[0].raw_affiliation_string | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Jazmyn McCloud |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[15].author.id | https://openalex.org/A5060731729 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Gurleen Roberts |
| authorships[15].affiliations[0].raw_affiliation_string | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Gurleen Roberts |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[16].author.id | https://openalex.org/A5059838758 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Deanna Crosby |
| authorships[16].affiliations[0].raw_affiliation_string | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Deanna Crosby |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[17].author.id | https://openalex.org/A5112632756 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Abirami Balajee |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[17].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[17].affiliations[1].institution_ids | https://openalex.org/I4210114436 |
| authorships[17].affiliations[1].raw_affiliation_string | Maximus Federal, Reston, Virginia, USA |
| authorships[17].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[17].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[17].institutions[0].type | government |
| authorships[17].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[17].institutions[1].id | https://openalex.org/I4210114436 |
| authorships[17].institutions[1].ror | https://ror.org/01yymmk41 |
| authorships[17].institutions[1].type | company |
| authorships[17].institutions[1].lineage | https://openalex.org/I4210114436 |
| authorships[17].institutions[1].country_code | US |
| authorships[17].institutions[1].display_name | Maximus (United States) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Abirami Balajee |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Maximus Federal, Reston, Virginia, USA |
| authorships[18].author.id | https://openalex.org/A5020089264 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-7541-6156 |
| authorships[18].author.display_name | Eleanor Burnett |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[18].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[18].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[18].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[18].institutions[0].type | government |
| authorships[18].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Eleanor Burnett |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[19].author.id | https://openalex.org/A5071475954 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-4080-3380 |
| authorships[19].author.display_name | Rebecca J. Chancey |
| authorships[19].countries | US |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[19].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[19].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[19].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[19].institutions[0].type | government |
| authorships[19].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[19].institutions[0].country_code | US |
| authorships[19].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Rebecca J Chancey |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[20].author.id | https://openalex.org/A5001758627 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-2058-5646 |
| authorships[20].author.display_name | Peter W. Cook |
| authorships[20].countries | US |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[20].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[20].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[20].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[20].institutions[0].type | government |
| authorships[20].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[20].institutions[0].country_code | US |
| authorships[20].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Peter Cook |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[21].author.id | https://openalex.org/A5043740494 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-6448-9587 |
| authorships[21].author.display_name | Morgane Donadel |
| authorships[21].countries | US |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[21].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[21].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[21].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[21].institutions[0].type | government |
| authorships[21].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[21].institutions[0].country_code | US |
| authorships[21].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Morgane Donadel |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[22].author.id | https://openalex.org/A5065100399 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-3883-0635 |
| authorships[22].author.display_name | Catherine Espinosa |
| authorships[22].countries | US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[22].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[22].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[22].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[22].institutions[0].type | government |
| authorships[22].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[22].institutions[0].country_code | US |
| authorships[22].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Catherine Espinosa |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[23].author.id | https://openalex.org/A5089234402 |
| authorships[23].author.orcid | https://orcid.org/0000-0003-1434-1714 |
| authorships[23].author.display_name | Mary E. Evans |
| authorships[23].countries | US |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[23].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[23].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[23].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[23].institutions[0].type | government |
| authorships[23].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[23].institutions[0].country_code | US |
| authorships[23].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Mary E Evans |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[24].author.id | https://openalex.org/A5024358117 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-4862-0650 |
| authorships[24].author.display_name | Katherine E. Fleming-Dutra |
| authorships[24].countries | US |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[24].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[24].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[24].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[24].institutions[0].type | government |
| authorships[24].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[24].institutions[0].country_code | US |
| authorships[24].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Katherine E Fleming-Dutra |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[25].author.id | https://openalex.org/A5076873447 |
| authorships[25].author.orcid | https://orcid.org/0000-0003-4986-9674 |
| authorships[25].author.display_name | Catalina Forero |
| authorships[25].countries | US |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[25].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[25].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[25].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[25].institutions[0].type | government |
| authorships[25].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[25].institutions[0].country_code | US |
| authorships[25].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Catalina Forero |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[26].author.id | https://openalex.org/A5036037450 |
| authorships[26].author.orcid | https://orcid.org/0000-0002-8655-3778 |
| authorships[26].author.display_name | Esther A. Kukielka |
| authorships[26].countries | US |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210130616 |
| authorships[26].affiliations[0].raw_affiliation_string | Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[26].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[26].affiliations[1].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[26].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[26].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[26].institutions[0].type | government |
| authorships[26].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[26].institutions[0].country_code | US |
| authorships[26].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[26].institutions[1].id | https://openalex.org/I4210130616 |
| authorships[26].institutions[1].ror | https://ror.org/03v64vs34 |
| authorships[26].institutions[1].type | government |
| authorships[26].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[26].institutions[1].country_code | US |
| authorships[26].institutions[1].display_name | Epidemic Intelligence Service |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Esther A Kukielka |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[27].author.id | https://openalex.org/A5100711399 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-2091-7313 |
| authorships[27].author.display_name | Yan Li |
| authorships[27].countries | US |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[27].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[27].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[27].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[27].institutions[0].type | government |
| authorships[27].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[27].institutions[0].country_code | US |
| authorships[27].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Yan Li |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[28].author.id | https://openalex.org/A5072384101 |
| authorships[28].author.orcid | https://orcid.org/0000-0002-0676-3020 |
| authorships[28].author.display_name | Paula L. Marcet |
| authorships[28].countries | US |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[28].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[28].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[28].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[28].institutions[0].type | government |
| authorships[28].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[28].institutions[0].country_code | US |
| authorships[28].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Paula L Marcet |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[29].author.id | https://openalex.org/A5080120318 |
| authorships[29].author.orcid | |
| authorships[29].author.display_name | Kiren Mitruka |
| authorships[29].countries | US |
| authorships[29].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[29].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[29].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[29].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[29].institutions[0].type | government |
| authorships[29].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[29].institutions[0].country_code | US |
| authorships[29].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Kiren Mitruka |
| authorships[29].is_corresponding | False |
| authorships[29].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[30].author.id | https://openalex.org/A5027087100 |
| authorships[30].author.orcid | |
| authorships[30].author.display_name | Jasmine Y. Nakayama |
| authorships[30].countries | US |
| authorships[30].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210130616 |
| authorships[30].affiliations[0].raw_affiliation_string | Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[30].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[30].affiliations[1].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[30].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[30].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[30].institutions[0].type | government |
| authorships[30].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[30].institutions[0].country_code | US |
| authorships[30].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[30].institutions[1].id | https://openalex.org/I4210130616 |
| authorships[30].institutions[1].ror | https://ror.org/03v64vs34 |
| authorships[30].institutions[1].type | government |
| authorships[30].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[30].institutions[1].country_code | US |
| authorships[30].institutions[1].display_name | Epidemic Intelligence Service |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Jasmine Y Nakayama |
| authorships[30].is_corresponding | False |
| authorships[30].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[31].author.id | https://openalex.org/A5003640752 |
| authorships[31].author.orcid | https://orcid.org/0000-0003-3920-3297 |
| authorships[31].author.display_name | Yoshinori Nakazawa |
| authorships[31].countries | US |
| authorships[31].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[31].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[31].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[31].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[31].institutions[0].type | government |
| authorships[31].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[31].institutions[0].country_code | US |
| authorships[31].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[31].author_position | middle |
| authorships[31].raw_author_name | Yoshinori Nakazawa |
| authorships[31].is_corresponding | False |
| authorships[31].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[32].author.id | https://openalex.org/A5089698290 |
| authorships[32].author.orcid | |
| authorships[32].author.display_name | Michelle O’Hegarty |
| authorships[32].countries | US |
| authorships[32].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[32].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[32].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[32].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[32].institutions[0].type | government |
| authorships[32].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[32].institutions[0].country_code | US |
| authorships[32].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[32].author_position | middle |
| authorships[32].raw_author_name | Michelle O’Hegarty |
| authorships[32].is_corresponding | False |
| authorships[32].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[33].author.id | https://openalex.org/A5084998825 |
| authorships[33].author.orcid | https://orcid.org/0000-0002-1706-4540 |
| authorships[33].author.display_name | Caroline Pratt |
| authorships[33].countries | US |
| authorships[33].affiliations[0].institution_ids | https://openalex.org/I1289490764, https://openalex.org/I4210130616 |
| authorships[33].affiliations[0].raw_affiliation_string | Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[33].affiliations[1].institution_ids | https://openalex.org/I1289490764 |
| authorships[33].affiliations[1].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[33].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[33].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[33].institutions[0].type | government |
| authorships[33].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[33].institutions[0].country_code | US |
| authorships[33].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[33].institutions[1].id | https://openalex.org/I4210130616 |
| authorships[33].institutions[1].ror | https://ror.org/03v64vs34 |
| authorships[33].institutions[1].type | government |
| authorships[33].institutions[1].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934, https://openalex.org/I4210130616 |
| authorships[33].institutions[1].country_code | US |
| authorships[33].institutions[1].display_name | Epidemic Intelligence Service |
| authorships[33].author_position | middle |
| authorships[33].raw_author_name | Caroline Pratt |
| authorships[33].is_corresponding | False |
| authorships[33].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[34].author.id | https://openalex.org/A5068154120 |
| authorships[34].author.orcid | |
| authorships[34].author.display_name | Marion E. Rice |
| authorships[34].countries | US |
| authorships[34].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[34].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[34].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[34].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[34].institutions[0].type | government |
| authorships[34].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[34].institutions[0].country_code | US |
| authorships[34].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[34].author_position | middle |
| authorships[34].raw_author_name | Marion E Rice |
| authorships[34].is_corresponding | False |
| authorships[34].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[35].author.id | https://openalex.org/A5040125270 |
| authorships[35].author.orcid | https://orcid.org/0000-0001-9354-0521 |
| authorships[35].author.display_name | Roxana M. Rodríguez Stewart |
| authorships[35].countries | US |
| authorships[35].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[35].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[35].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[35].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[35].institutions[0].type | government |
| authorships[35].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[35].institutions[0].country_code | US |
| authorships[35].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[35].author_position | middle |
| authorships[35].raw_author_name | Roxana M Rodriguez Stewart |
| authorships[35].is_corresponding | False |
| authorships[35].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[36].author.id | https://openalex.org/A5006763454 |
| authorships[36].author.orcid | |
| authorships[36].author.display_name | Raquel Sabogal |
| authorships[36].countries | US |
| authorships[36].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[36].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[36].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[36].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[36].institutions[0].type | government |
| authorships[36].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[36].institutions[0].country_code | US |
| authorships[36].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[36].author_position | middle |
| authorships[36].raw_author_name | Raquel Sabogal |
| authorships[36].is_corresponding | False |
| authorships[36].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[37].author.id | https://openalex.org/A5073747196 |
| authorships[37].author.orcid | |
| authorships[37].author.display_name | Emanny Sánchez |
| authorships[37].countries | US |
| authorships[37].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[37].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[37].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[37].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[37].institutions[0].type | government |
| authorships[37].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[37].institutions[0].country_code | US |
| authorships[37].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[37].author_position | middle |
| authorships[37].raw_author_name | Emanny Sanchez |
| authorships[37].is_corresponding | False |
| authorships[37].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[38].author.id | https://openalex.org/A5081377951 |
| authorships[38].author.orcid | https://orcid.org/0000-0003-1538-9373 |
| authorships[38].author.display_name | Andrés Velasco-Villa |
| authorships[38].countries | US |
| authorships[38].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[38].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[38].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[38].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[38].institutions[0].type | government |
| authorships[38].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[38].institutions[0].country_code | US |
| authorships[38].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[38].author_position | middle |
| authorships[38].raw_author_name | Andres Velasco-Villa |
| authorships[38].is_corresponding | False |
| authorships[38].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[39].author.id | https://openalex.org/A5025378912 |
| authorships[39].author.orcid | https://orcid.org/0000-0002-7902-2602 |
| authorships[39].author.display_name | Mark K. Weng |
| authorships[39].countries | US |
| authorships[39].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[39].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[39].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[39].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[39].institutions[0].type | government |
| authorships[39].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[39].institutions[0].country_code | US |
| authorships[39].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[39].author_position | middle |
| authorships[39].raw_author_name | Mark K Weng |
| authorships[39].is_corresponding | False |
| authorships[39].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[40].author.id | https://openalex.org/A5062617254 |
| authorships[40].author.orcid | https://orcid.org/0000-0001-7525-2075 |
| authorships[40].author.display_name | Jing Zhang |
| authorships[40].countries | US |
| authorships[40].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[40].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[40].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[40].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[40].institutions[0].type | government |
| authorships[40].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[40].institutions[0].country_code | US |
| authorships[40].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[40].author_position | middle |
| authorships[40].raw_author_name | Jing Zhang |
| authorships[40].is_corresponding | False |
| authorships[40].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[41].author.id | https://openalex.org/A5059936572 |
| authorships[41].author.orcid | |
| authorships[41].author.display_name | Grant Rivera |
| authorships[41].countries | US |
| authorships[41].affiliations[0].institution_ids | https://openalex.org/I81726945 |
| authorships[41].affiliations[0].raw_affiliation_string | Marietta City Schools, Marietta, Georgia, USA |
| authorships[41].institutions[0].id | https://openalex.org/I81726945 |
| authorships[41].institutions[0].ror | https://ror.org/03apb0g70 |
| authorships[41].institutions[0].type | education |
| authorships[41].institutions[0].lineage | https://openalex.org/I81726945 |
| authorships[41].institutions[0].country_code | US |
| authorships[41].institutions[0].display_name | Marietta College |
| authorships[41].author_position | middle |
| authorships[41].raw_author_name | Grant Rivera |
| authorships[41].is_corresponding | False |
| authorships[41].raw_affiliation_strings | Marietta City Schools, Marietta, Georgia, USA |
| authorships[42].author.id | https://openalex.org/A5111680917 |
| authorships[42].author.orcid | |
| authorships[42].author.display_name | Tonia Parrott |
| authorships[42].countries | US |
| authorships[42].affiliations[0].institution_ids | https://openalex.org/I4210140731 |
| authorships[42].affiliations[0].raw_affiliation_string | Georgia Public Health Laboratory, Decatur, Georgia, USA |
| authorships[42].institutions[0].id | https://openalex.org/I4210140731 |
| authorships[42].institutions[0].ror | https://ror.org/04wcf8366 |
| authorships[42].institutions[0].type | government |
| authorships[42].institutions[0].lineage | https://openalex.org/I4210140731 |
| authorships[42].institutions[0].country_code | US |
| authorships[42].institutions[0].display_name | Georgia Department of Public Health |
| authorships[42].author_position | middle |
| authorships[42].raw_author_name | Tonia Parrott |
| authorships[42].is_corresponding | False |
| authorships[42].raw_affiliation_strings | Georgia Public Health Laboratory, Decatur, Georgia, USA |
| authorships[43].author.id | https://openalex.org/A5003365164 |
| authorships[43].author.orcid | https://orcid.org/0000-0002-2614-4665 |
| authorships[43].author.display_name | Rachel S. Franklin |
| authorships[43].affiliations[0].raw_affiliation_string | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[43].author_position | middle |
| authorships[43].raw_author_name | Rachel Franklin |
| authorships[43].is_corresponding | False |
| authorships[43].raw_affiliation_strings | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[44].author.id | https://openalex.org/A5072388130 |
| authorships[44].author.orcid | |
| authorships[44].author.display_name | Janet Memark |
| authorships[44].affiliations[0].raw_affiliation_string | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[44].author_position | middle |
| authorships[44].raw_author_name | Janet Memark |
| authorships[44].is_corresponding | False |
| authorships[44].raw_affiliation_strings | Cobb and Douglas Public Health, Marietta, Georgia, USA |
| authorships[45].author.id | https://openalex.org/A5049066802 |
| authorships[45].author.orcid | |
| authorships[45].author.display_name | Cherie Drenzek |
| authorships[45].countries | US |
| authorships[45].affiliations[0].institution_ids | https://openalex.org/I4210140731 |
| authorships[45].affiliations[0].raw_affiliation_string | Georgia Department of Public Health, Atlanta, Georgia, USA |
| authorships[45].institutions[0].id | https://openalex.org/I4210140731 |
| authorships[45].institutions[0].ror | https://ror.org/04wcf8366 |
| authorships[45].institutions[0].type | government |
| authorships[45].institutions[0].lineage | https://openalex.org/I4210140731 |
| authorships[45].institutions[0].country_code | US |
| authorships[45].institutions[0].display_name | Georgia Department of Public Health |
| authorships[45].author_position | middle |
| authorships[45].raw_author_name | Cherie Drenzek |
| authorships[45].is_corresponding | False |
| authorships[45].raw_affiliation_strings | Georgia Department of Public Health, Atlanta, Georgia, USA |
| authorships[46].author.id | https://openalex.org/A5067685734 |
| authorships[46].author.orcid | https://orcid.org/0000-0001-7250-1013 |
| authorships[46].author.display_name | Aron J. Hall |
| authorships[46].countries | US |
| authorships[46].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[46].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[46].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[46].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[46].institutions[0].type | government |
| authorships[46].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[46].institutions[0].country_code | US |
| authorships[46].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[46].author_position | middle |
| authorships[46].raw_author_name | Aron J Hall |
| authorships[46].is_corresponding | False |
| authorships[46].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[47].author.id | https://openalex.org/A5108223952 |
| authorships[47].author.orcid | |
| authorships[47].author.display_name | Hannah L. Kirking |
| authorships[47].countries | US |
| authorships[47].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[47].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[47].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[47].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[47].institutions[0].type | government |
| authorships[47].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[47].institutions[0].country_code | US |
| authorships[47].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[47].author_position | middle |
| authorships[47].raw_author_name | Hannah L Kirking |
| authorships[47].is_corresponding | False |
| authorships[47].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[48].author.id | https://openalex.org/A5061848201 |
| authorships[48].author.orcid | https://orcid.org/0000-0002-8114-6196 |
| authorships[48].author.display_name | Jacqueline E. Tate |
| authorships[48].countries | US |
| authorships[48].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[48].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[48].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[48].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[48].institutions[0].type | government |
| authorships[48].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[48].institutions[0].country_code | US |
| authorships[48].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[48].author_position | middle |
| authorships[48].raw_author_name | Jacqueline E Tate |
| authorships[48].is_corresponding | False |
| authorships[48].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[49].author.id | https://openalex.org/A5072347654 |
| authorships[49].author.orcid | https://orcid.org/0000-0003-4149-9840 |
| authorships[49].author.display_name | Snigdha Vallabhaneni |
| authorships[49].countries | US |
| authorships[49].affiliations[0].institution_ids | https://openalex.org/I1289490764 |
| authorships[49].affiliations[0].raw_affiliation_string | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| authorships[49].institutions[0].id | https://openalex.org/I1289490764 |
| authorships[49].institutions[0].ror | https://ror.org/042twtr12 |
| authorships[49].institutions[0].type | government |
| authorships[49].institutions[0].lineage | https://openalex.org/I1289490764, https://openalex.org/I1299022934 |
| authorships[49].institutions[0].country_code | US |
| authorships[49].institutions[0].display_name | Centers for Disease Control and Prevention |
| authorships[49].author_position | last |
| authorships[49].raw_author_name | Snigdha Vallabhaneni |
| authorships[49].is_corresponding | False |
| authorships[49].raw_affiliation_strings | COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District—United States, December 2020–January 2021 |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11754 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9988999962806702 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 detection and testing |
| related_works | https://openalex.org/W4295860453, https://openalex.org/W3154254733, https://openalex.org/W3173782811, https://openalex.org/W3215665879, https://openalex.org/W3163843429, https://openalex.org/W2381221361, https://openalex.org/W2127290136, https://openalex.org/W2382061463, https://openalex.org/W2348362992, https://openalex.org/W3016368675 |
| cited_by_count | 28 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 5 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 10 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 7 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1093/cid/ciab332 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S72350973 |
| best_oa_location.source.issn | 1058-4838, 1537-6591 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1058-4838 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Clinical Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | public-domain |
| best_oa_location.pdf_url | https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/public-domain |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/cid/ciab332 |
| primary_location.id | doi:10.1093/cid/ciab332 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S72350973 |
| primary_location.source.issn | 1058-4838, 1537-6591 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1058-4838 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Clinical Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | public-domain |
| primary_location.pdf_url | https://academic.oup.com/cid/article-pdf/74/2/319/42332261/ciab332.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/public-domain |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/cid/ciab332 |
| publication_date | 2021-04-16 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W3092141513, https://openalex.org/W3113247482, https://openalex.org/W3040555232, https://openalex.org/W2789843538, https://openalex.org/W2108234281, https://openalex.org/W6739921776, https://openalex.org/W2952045272, https://openalex.org/W3043124965, https://openalex.org/W1507985183, https://openalex.org/W6780660208, https://openalex.org/W3132640118, https://openalex.org/W3125426123, https://openalex.org/W3118777904, https://openalex.org/W6800099784, https://openalex.org/W3046644245, https://openalex.org/W3111440965, https://openalex.org/W3139195769, https://openalex.org/W3136336001, https://openalex.org/W6787881161, https://openalex.org/W3134672006, https://openalex.org/W3111985903, https://openalex.org/W3152357615, https://openalex.org/W6790964259, https://openalex.org/W3112456938, https://openalex.org/W3130220433, https://openalex.org/W3125833607, https://openalex.org/W3123418622, https://openalex.org/W3092976950, https://openalex.org/W3131527546, https://openalex.org/W3137840839, https://openalex.org/W3198676969, https://openalex.org/W3150545588, https://openalex.org/W3112599970, https://openalex.org/W2951878836, https://openalex.org/W3192505913 |
| referenced_works_count | 35 |
| abstract_inverted_index.1 | 33 |
| abstract_inverted_index.2 | 16 |
| abstract_inverted_index.a | 26, 217 |
| abstract_inverted_index.15 | 127 |
| abstract_inverted_index.31 | 147 |
| abstract_inverted_index.55 | 139 |
| abstract_inverted_index.86 | 108, 129 |
| abstract_inverted_index.To | 2 |
| abstract_inverted_index.We | 106 |
| abstract_inverted_index.be | 254 |
| abstract_inverted_index.by | 49, 86 |
| abstract_inverted_index.in | 21, 25, 45, 134, 154, 228 |
| abstract_inverted_index.is | 239 |
| abstract_inverted_index.of | 10, 116, 121, 128, 223, 259 |
| abstract_inverted_index.to | 76, 219, 241 |
| abstract_inverted_index.vs | 189, 204 |
| abstract_inverted_index.we | 6, 58 |
| abstract_inverted_index.679 | 122 |
| abstract_inverted_index.688 | 114 |
| abstract_inverted_index.CI, | 169, 177, 187, 195, 202, 210 |
| abstract_inverted_index.For | 55 |
| abstract_inverted_index.SAR | 180 |
| abstract_inverted_index.The | 179 |
| abstract_inverted_index.and | 19, 41, 51, 61, 73, 80, 100, 111, 171, 197 |
| abstract_inverted_index.for | 183, 198 |
| abstract_inverted_index.may | 215 |
| abstract_inverted_index.the | 8, 220 |
| abstract_inverted_index.was | 181 |
| abstract_inverted_index.(eg, | 89 |
| abstract_inverted_index.(ie, | 97 |
| abstract_inverted_index.1119 | 112 |
| abstract_inverted_index.2019 | 237 |
| abstract_inverted_index.SARs | 152 |
| abstract_inverted_index.[95% | 160, 168, 176, 186, 194, 201, 209 |
| abstract_inverted_index.case | 95, 102 |
| abstract_inverted_index.many | 246 |
| abstract_inverted_index.pose | 216 |
| abstract_inverted_index.rate | 84 |
| abstract_inverted_index.risk | 218 |
| abstract_inverted_index.role | 96 |
| abstract_inverted_index.safe | 221 |
| abstract_inverted_index.that | 233 |
| abstract_inverted_index.were | 47, 149, 153, 249 |
| abstract_inverted_index.whom | 117 |
| abstract_inverted_index.with | 143, 256 |
| abstract_inverted_index.≥2 | 135 |
| abstract_inverted_index.(3.0% | 208 |
| abstract_inverted_index.(5.8% | 193 |
| abstract_inverted_index.(9.5% | 175 |
| abstract_inverted_index.(SAR) | 85 |
| abstract_inverted_index.2021, | 37 |
| abstract_inverted_index.Among | 138 |
| abstract_inverted_index.acute | 12 |
| abstract_inverted_index.cases | 40, 110, 132, 192, 207 |
| abstract_inverted_index.chain | 66 |
| abstract_inverted_index.close | 43 |
| abstract_inverted_index.data, | 146 |
| abstract_inverted_index.index | 39, 94, 101, 109, 131, 191, 206 |
| abstract_inverted_index.staff | 165, 184, 229 |
| abstract_inverted_index.their | 42 |
| abstract_inverted_index.which | 22 |
| abstract_inverted_index.{CI}, | 163 |
| abstract_inverted_index.(10.9% | 200 |
| abstract_inverted_index.(13.1% | 185 |
| abstract_inverted_index.(18.2% | 167 |
| abstract_inverted_index.(23.8% | 159 |
| abstract_inverted_index.(8.7%) | 123 |
| abstract_inverted_index.During | 32 |
| abstract_inverted_index.Indoor | 213 |
| abstract_inverted_index.attack | 83 |
| abstract_inverted_index.extent | 9 |
| abstract_inverted_index.health | 53 |
| abstract_inverted_index.higher | 182 |
| abstract_inverted_index.inform | 3 |
| abstract_inverted_index.paired | 255 |
| abstract_inverted_index.public | 28, 52 |
| abstract_inverted_index.school | 29, 50, 87, 92, 173 |
| abstract_inverted_index.severe | 11 |
| abstract_inverted_index.should | 253 |
| abstract_inverted_index.sports | 157, 214 |
| abstract_inverted_index.staff, | 98 |
| abstract_inverted_index.tested | 125 |
| abstract_inverted_index.(17.4%) | 130 |
| abstract_inverted_index.(56.4%) | 148 |
| abstract_inverted_index.(61.5%) | 115 |
| abstract_inverted_index.Because | 245 |
| abstract_inverted_index.Georgia | 27 |
| abstract_inverted_index.Highest | 151 |
| abstract_inverted_index.January | 36 |
| abstract_inverted_index.Methods | 31 |
| abstract_inverted_index.Results | 105 |
| abstract_inverted_index.contact | 251 |
| abstract_inverted_index.disease | 236 |
| abstract_inverted_index.include | 234 |
| abstract_inverted_index.indoor, | 155 |
| abstract_inverted_index.offered | 62 |
| abstract_inverted_index.persons | 140 |
| abstract_inverted_index.schools | 46 |
| abstract_inverted_index.setting | 88 |
| abstract_inverted_index.sports, | 90 |
| abstract_inverted_index.status. | 104 |
| abstract_inverted_index.student | 190 |
| abstract_inverted_index.symptom | 145 |
| abstract_inverted_index.testing | 141 |
| abstract_inverted_index.through | 231 |
| abstract_inverted_index.tracing | 252 |
| abstract_inverted_index.(RT-PCR) | 68 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.December | 34 |
| abstract_inverted_index.assessed | 7, 59 |
| abstract_inverted_index.contacts | 44, 124, 248 |
| abstract_inverted_index.critical | 240 |
| abstract_inverted_index.identify | 77 |
| abstract_inverted_index.interval | 162 |
| abstract_inverted_index.measures | 232 |
| abstract_inverted_index.members, | 230 |
| abstract_inverted_index.occurred | 24 |
| abstract_inverted_index.positive | 136, 142, 247 |
| abstract_inverted_index.reaction | 67 |
| abstract_inverted_index.received | 118 |
| abstract_inverted_index.reducing | 242 |
| abstract_inverted_index.resulted | 133 |
| abstract_inverted_index.settings | 20, 158 |
| abstract_inverted_index.symptoms | 60 |
| abstract_inverted_index.syndrome | 14 |
| abstract_inverted_index.testing, | 257 |
| abstract_inverted_index.testing. | 119 |
| abstract_inverted_index.testing; | 69 |
| abstract_inverted_index.2020–22 | 35 |
| abstract_inverted_index.available | 144 |
| abstract_inverted_index.contacts, | 57, 113 |
| abstract_inverted_index.contacts. | 137 |
| abstract_inverted_index.district. | 30 |
| abstract_inverted_index.in-person | 224 |
| abstract_inverted_index.in-school | 56, 78, 243 |
| abstract_inverted_index.infection | 227 |
| abstract_inverted_index.learning. | 225 |
| abstract_inverted_index.operation | 222 |
| abstract_inverted_index.performed | 70 |
| abstract_inverted_index.positive; | 126 |
| abstract_inverted_index.secondary | 82 |
| abstract_inverted_index.student), | 99 |
| abstract_inverted_index.symptoms. | 260 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Fifty-nine | 120 |
| abstract_inverted_index.Preventing | 226 |
| abstract_inverted_index.SARS-CoV-2 | 63 |
| abstract_inverted_index.calculated | 81 |
| abstract_inverted_index.classrooms | 174 |
| abstract_inverted_index.confidence | 161 |
| abstract_inverted_index.elementary | 91, 172 |
| abstract_inverted_index.identified | 48, 107 |
| abstract_inverted_index.officials. | 54 |
| abstract_inverted_index.polymerase | 65 |
| abstract_inverted_index.prevention | 4 |
| abstract_inverted_index.regardless | 258 |
| abstract_inverted_index.sequencing | 75 |
| abstract_inverted_index.Conclusions | 212 |
| abstract_inverted_index.classroom), | 93 |
| abstract_inverted_index.coronavirus | 15, 235 |
| abstract_inverted_index.respiratory | 13 |
| abstract_inverted_index.strategies, | 5 |
| abstract_inverted_index.symptomatic | 103, 199 |
| abstract_inverted_index.(SARS-CoV-2) | 17 |
| abstract_inverted_index.asymptomatic | 205 |
| abstract_inverted_index.high-contact | 156 |
| abstract_inverted_index.transmission | 18, 23 |
| abstract_inverted_index.vaccination, | 238 |
| abstract_inverted_index.whole-genome | 74 |
| abstract_inverted_index.3.6%–8.0%]) | 196 |
| abstract_inverted_index.asymptomatic, | 250 |
| abstract_inverted_index.asymptomatic. | 150 |
| abstract_inverted_index.epidemiologic | 71 |
| abstract_inverted_index.transmission. | 244 |
| abstract_inverted_index.transmission; | 79 |
| abstract_inverted_index.1.0%–5.5%]). | 211 |
| abstract_inverted_index.8.1%–13.9%]) | 203 |
| abstract_inverted_index.9.0%–17.2%]) | 188 |
| abstract_inverted_index.investigations | 72 |
| abstract_inverted_index.4.5%–31.8%]), | 170 |
| abstract_inverted_index.6.5%–12.5%]). | 178 |
| abstract_inverted_index.12.7%–33.3%]), | 164 |
| abstract_inverted_index.meetings/lunches | 166 |
| abstract_inverted_index.SARS-CoV-2–infected | 38 |
| abstract_inverted_index.reverse-transcription | 64 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 95 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 50 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.87373984 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |